XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.65

-0.8%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (9149)	3/12/1999 4:53:00 PM
From: aknahow	Read Replies (1) of 17367

From the 10K "The Company is also considering adapting the facility to expand production of its NEUPREX(R) product. This adaptation, if pursued, is estimated to cost significantly less than a new facility. The Company's current estimate of net cash flows from NEUPREX(R) that would be manufactured in the facility exceeds the current carrying value of the facility plus anticipated costs to renovate it for NEUPREX(R) production. If the Company pursues this alternative, the actual net cash flows that the Company will ultimately realize as well as the estimated costs to renovate the facility could differ materially from the estimated amounts."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next